Table 6 Gender-specific risk factors of survival in TAA patients after thoracic aortic surgery

Maximum indexed aortic diameter

0.022

1.076(1.011–1.145)

Maximum aortic diameter

0.006

1.050(1.014–1.088)

Renal failure

<0.001

21.794(7.707–61.634)

Aortic insufficiency

0.027

0.349(0.138–0.885)

Cardiopulmonary bypass time

<0.001

1.018(1.009–1.026)

Cross clamp period

0.02

1.016(1.003–1.030)

Circulatory arrest

<0.001

1.081(1.055–1.108)

Aortic arch involvement

<0.001

13.749(5.413–34.923)

ICU stay

0.008

1.055(1.014–1.098)

Overall hospital stay

<0.001

1.034(1.016–1.052)

Arch or/and descending aortic involvement

<0.001

26.746(9.457–75.637)

Female

Pvalue

HR (95% CI)

Maximum indexed aortic diameter

0.027

7.357 (1.250-43.299)

Cross clamp time

0.033

1.181 (1.014–1.377)

NYHA I

0.021

0.068 (0.007–0.666)

NYHA II

0.043

0.082 (0.007–0.922)